Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-03-14

Clinical Trial Update: Influencing Wound Healing Through the Application of Hyaluronic Acid With Perfluorodecalin and Physalis Angulata Extract After Split Skin Removal From the Thigh - A Study in "Split Wound Design" [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating hyaluronic acid with perfluorodecalin and Physalis angulata extract for wound healing after split-thickness skin removal has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyaluronic acid with perfluorodecalin and Physalis angulata extract

Snippet

Sponsor: RWTH Aachen University | Conditions: Wound Heal | Phase 3 | Status: WITHDRAWN